Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Thiol-responsive polypeptide sulfur dioxide prodrug nanoparticles for effective tumor inhibition
A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer's disease models
Our mission is to help you achieve sustainable health, and that starts with the principle of doing no harm
Source: Rutgers A medication commonly used to treat Type 2 diabetes and obesity was associated with a slight increase in risk for a rare condition involving reduced blood flow to the optic nerve that can cause sudden vision loss, according to Rutgers researchers
is supported by the University of British Columbia Clinician Investigator Program and a Canadian Institutes of Health Research (CIHR) Canada Graduate ScholarshipMasters Award
/product/41/5015682/1.jpg?5024)
